News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|May 23, 2016

Distinguishing Melanoma From Other Skin Cancers

Episodes in this series

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 2 Detecting Melanoma That Has Spread

EP. 2 Detecting Melanoma That Has Spread

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 6 Top Concerns of Patients

EP. 6 Top Concerns of Patients

EP. 7 Additional Approaches in Advanced Melanoma

EP. 7 Additional Approaches in Advanced Melanoma

Newsletter

Stay up to date on cancer updates, research and education

Related Content

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric patients with T-ALL and T-LBL: © stock.adobe.com.

FDA Approves Larger Nelarabine Vial for Some Leukemias and Lymphomas

January 29th 2026

Dr. Ariel Ostad explains how addressing uncertainty and scananxiety through communication and support can improve the cancer care experience for patients.

The Emotional Side of Cancer Care Beyond Medical Treatment

January 28th 2026

Image of Tracy.

Managing Nutrition Changes in Patients With Gastrointestinal Cancers

ByDr. Tracy Proverbs-Singh

January 28th 2026

Image of Kim.

Grieving After Cancer: Advice for Those Grieving and Supporting Them

January 28th 2026

A phase 2 trial showed onvansertib plus FOLFIRI and Avastin improved response and disease control in first-line RAS-mutated metastatic colorectal cancer: © stock.adobe.com.

Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

January 28th 2026

Trending on CURE

Cancer and Answering the Phone

Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

Besremi Recognized by Updated Guidelines for Essential Thrombocythemia

Grieving After Cancer: Advice for Those Grieving and Supporting Them

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers